New research shows women with inflammatory bowel disease (IBD) have dramatically higher pregnancy rates with embryo transfer (73%) than with intrauterine insemination (10%), especially if they have had prior pelvic surgery.
New data from the OPTION-VMS study shows fezolinetant (Veozah) improves hot flash bother, work productivity, and mood in menopausal women within 12 weeks, confirming trial results in everyday practice.
A new study examines the thromboembolic risks of menopausal hormone therapy. Separately, research reveals significant gender disparities in the diagnosis of autoimmune conditions.
The FDA has approved pritelivir tablets for immunocompromised adults with herpes simplex virus lesions that have not responded to standard antiviral treatments.
A government-commissioned review finds England's mental health and autism assessment system is failing young people.
NHS England faces record September A&E activity and a second monthly rise in waiting lists, with 7.37 million treatments pending.
Ten NHS mental health trusts have been referred to the Care Quality Commission after an internal review found failures in patient consent procedures for digital monitoring systems like Oxevision. The referral comes as the Lampard Inquiry examines patient safety, including the use of infrared technology to monitor patients without proper consent.
The American College of Physicians now strongly recommends estrogen-progestogen as first-line treatment for menopausal hot flashes and night sweats.
A global study of over 6 million people reveals women self-report higher pain prevalence than men across all body sites.
Updated mRNA flu and COVID-19 vaccines are available this fall, with medical societies strongly recommending October vaccination for high-risk groups.
A new study shows patient navigators dramatically improve postpartum care access and outcomes for low-income pregnant individuals.
Three Republican-led states filed a direct lawsuit at the U.S. Supreme Court on Wednesday, challenging shield laws in New York, California, and Massachusetts that protect providers mailing abortion pills into ban states.
A landmark study finds treating both women and their male partners for bacterial vaginosis dramatically reduces recurrence.
A 2024 study found infections caused 2.3 million new cancer cases worldwide, with HPV and H. Pylori each linked to roughly 750,000 cases.
Women's health in Europe by life stage and by the condition that tends to go under-explained within it. Cycle, Fertility & pregnancy and Menopause follow the stages, Conditions carries the clinical reporting, and Care & systems covers access and how services actually work.
No. Every piece is a summary of published research, health authority material or named reporting, and nobody here is presented as a clinician or as having reviewed it. The sources are named so you can take them to a professional.
No. Nothing here is a diagnosis or a treatment plan, and symptoms that are severe, sudden or persistent need clinical attention rather than a website. Where guidance appears, the piece names the body that issued it.
From journals, health services, regulators and named publications, credited and linked in each article. Where evidence is contested, the piece reports it as contested rather than picking a side.
They are written with automated assistance from the source material and carry no individual byline, crediting the source publication where an author would appear. No clinician is named as an author or a reviewer, because none has been involved.
Not with us. There are no cookies, no analytics and no third-party requests at all, which matters more on a health site than most. Only your theme choice is stored, locally.